You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Sale Disclosure
Posard Matthew L. · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$11K
Posard Matthew L. Director
HALO
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$106.94
Oct 1, 2026
First close after public filing
$108.31
Oct 5, 2026
30-day return after filing
+19.06%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 100 shares @ $110.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000133
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$567.66K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 1, 2026 | $78.23K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 1, 2026 | $357.9K |
| Halozyme Therapeutics, Inc. HALO | Sale | Oct 1, 2026 | $120.53K |
| Halozyme Therapeutics, Inc. HALO Current | Sale | Oct 1, 2026 | $11K |